Neuralink, Elon Musk’s brain implant startup, quietly secures additional $43m amid controversy

In a recent SEC filing, Neuralink disclosed an additional $43 million in venture capital, expanding on a previous funding round led by Peter Thiel’s Founders Fund.

This brings the total to $323 million, up from the initial $280 million raised in August. Neuralink, established in 2016, specializes in implantable chips designed to read brain waves, using a unique sewing machine-like device to insert ultra-thin threads into the brain, which connect to a custom chip featuring electrodes.

While Neuralink obtained FDA approval for human clinical trials, it is currently under increased scrutiny due to allegations of a toxic workplace culture and unethical research practices. Reports have emerged about a work environment characterized by blame and fear, with Musk allegedly undermining management.

Additionally, concerns have been raised about the mistreatment of monkeys involved in Neuralink's trials, including claims of psychological distress and chronic infections.